scholarly journals Long-Term Efficacy of Modified-Release Recombinant Human Thyrotropin Augmented Radioiodine Therapy for Benign Multinodular Goiter: Results from a Multicenter, International, Randomized, Placebo-Controlled, Dose-Selection Study

Thyroid ◽  
2014 ◽  
Vol 24 (4) ◽  
pp. 727-735 ◽  
Author(s):  
Søren Fast ◽  
Laszlo Hegedüs ◽  
Furio Pacini ◽  
Aldo Pinchera ◽  
Angela M. Leung ◽  
...  
Keyword(s):  
Multinodular Goiter ◽  
Radioiodine Therapy ◽  
Modified Release ◽  
Dose Selection ◽  
Term Efficacy ◽  
Recombinant Human Thyrotropin

scholarly journals Változások a pajzsmirigybetegségek radiojódkezelésében

2016 ◽  
Vol 157 (3) ◽  
pp. 83-88
Author(s):  
András Konrády
Keyword(s):  
Multinodular Goiter ◽  
Radioiodine Therapy ◽  
Treatment Protocol ◽  
Treatment Results ◽  
Radioiodine Uptake ◽  
Risk Patients ◽  
Toxic Multinodular Goiter ◽  
Prospective Trials ◽  
Immunogenic Hyperthyroidism ◽  
Recombinant Human Thyrotropin

Radioiodine therapy for benign and malignant thyroid diseases was introduced about 70 years ago, however, there is still a lack of consensus regarding indications, doses and procedure. This review covers treatment results in immunogenic hyperthyroidism including the problem of orbitopathy. Radioiodine therapy for toxic and non-toxic multinodular goiter is also discussed with striking possibility of enhanching the radioiodine uptake. In this respect the recombinant human thyrotropin should be mentioned. Thyroid cancer treatment protocol has changed, too, due to ineffectivity in low-risk patients. More attention is needed to the carcinogenecity of radioiodine. The numerous problems mentioned above require large and well-designed prospective trials to resolve the fundamental questions. The author emphasizes that radioiodine dose should be administered in doses as low as reasonably achievable. Orv. Hetil., 2016, 157(3), 83–88.

scholarly journals Prestimulation with Recombinant Human Thyrotropin (rhTSH) Improves the Long-Term Outcome of Radioiodine Therapy for Multinodular Nontoxic Goiter

2012 ◽  
Vol 97 (8) ◽  
pp. 2653-2660 ◽  
Author(s):  
Søren Fast ◽  
Viveque Egsgaard Nielsen ◽  
Peter Grupe ◽  
Henrik Boel-Jørgensen ◽  
Lars Bastholt ◽  
...  
Keyword(s):  
Radioiodine Therapy ◽  
Term Outcome ◽  
Long Term Outcome ◽  
Nontoxic Goiter ◽  
Recombinant Human Thyrotropin

CO2 Laser Offers Long-Term Efficacy

2008 ◽  
Vol 39 (9) ◽  
pp. 31
Author(s):  
ROBIN TURNER
Keyword(s):  
Co2 Laser ◽  
Term Efficacy

Denosumab Delivered Long-Term Efficacy

2011 ◽  
Vol 41 (17) ◽  
pp. 16-17
Author(s):  
BRUCE JANCIN
Keyword(s):  
Term Efficacy
Sign in / Sign up

Export Citation Format

Share Document